Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Dae Im Jung"'
Autor:
Sang Hwan Seo, Jung-ah Choi, Dae-Im Jung, Yunjeong Park, Eunji Yang, Seohee Jung, Taesoo Kwon, Soon-Hwan Kwon, Manki Song
Publikováno v:
Virology Journal, Vol 21, Iss 1, Pp 1-13 (2024)
Abstract Background Human adenovirus type 55 (hAd55) infection can lead to acute respiratory diseases that often present with severe symptoms. Despite its persistent prevalence in military camps and communities, there are no commercially available va
Externí odkaz:
https://doaj.org/article/f8ae031829fd41dcb270d13cf889d74b
Autor:
In Su Cheon, Byoung-Shik Shim, Sung-Moo Park, Youngjoo Choi, Ji Eun Jang, Dae Im Jung, Jae-Ouk Kim, Jun Chang, Cheol-Heui Yun, Man Ki Song
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e94269 (2014)
Respiratory syncytial virus (RSV) is a major cause of respiratory tract infection in infants and young children worldwide, but currently no safe and effective vaccine is available. The RSV G glycoprotein (RSVG), a major attachment protein, is an impo
Externí odkaz:
https://doaj.org/article/9ec5e22f57cd45509e1e960f99d74acf
Autor:
Jae-Yong Kim, Kyeongseok Jeon, Jung Joo Hong, Sang-In Park, Hyeonggon Cho, Hyo-Jung Park, Hye Won Kwak, Hyeong-Jun Park, Yoo-Jin Bang, Yu-Sun Lee, Seo-Hyeon Bae, So-Hee Kim, Kyung-Ah Hwang, Dae-Im Jung, Seong Hoo Cho, Sang Hwan Seo, Green Kim, Hanseul Oh, Hwal-Yong Lee, Ki Hyun Kim, Hee-Young Lim, Pyeonghwa Jeon, Joo-Yeon Lee, Junho Chung, Sang-Myeong Lee, Hae Li Ko, Manki Song, Nam-Hyuk Cho, Young-suk Lee, So-Hee Hong, Jae-Hwan Nam
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract Severe fever with thrombocytopenia syndrome virus was first discovered in 2009 as the causative agent of severe fever with thrombocytopenia syndrome. Despite its potential threat to public health, no prophylactic vaccine is yet available. Th
Externí odkaz:
https://doaj.org/article/595caf71034941448061581088917336
Autor:
Jae-Yong Kim, Kyeongseok Jeon, Jung Joo Hong, Sang-In Park, Hyeong-Gon Cho, Hyo-Jung Park, Hye Won Kwak, Hyeong-Jun Park, Yoo-Jin Bang, Yu-Sun Lee, Seo-Hyeon Bae, So-Hee Kim, Kyung-Ah Hwang, Dae-Im Jung, Seong Hoo Cho, Sang Hwan Seo, Green Kim, Hanseul Oh, Hwal-Yong Lee, Ki Hyun Kim, Hee-Young Lim, Pyeonghwa Jeon, Joo-Yeon Lee, Junho Chung, Sang-Myeong Lee, Hae Li Ko, Manki Song, Nam-Hyuk Cho, Young-suk Lee, So-Hee Hong, Jae-Hwan Nam
Severe Fever with Thrombocytopenia Syndrome Virus(SFTSV) was first discovered in 2009 as the causative agent of severe fever with thrombocytopenia syndrome. Despite its potential threat to public health, no prophylactic vaccine is yet available. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::289f6cd8b1611749fab4a32ead689c7b
https://doi.org/10.21203/rs.3.rs-2420776/v1
https://doi.org/10.21203/rs.3.rs-2420776/v1
Autor:
Uni Park, Jae Myun Lee, Manki Song, Junghyun Goo, Dae Im Jung, Jung-ah Choi, Hyeja Lee, Jae-Ouk Kim, Eunji Yang, Hayan Park, Semi Rho, Young Hye Moon, Young Shin Park, Se-Na Lee, Sang Hwan Seo, Yuji Jeong, Nam Hyuk Cho
Publikováno v:
Journal of Virology
Coronavirus is an RNA virus with a higher mutation rate than DNA viruses. Therefore, a mutation in S-protein, which mediates viral infection by binding to a human cellular receptor, is expected to cause difficulties in vaccine development. Given that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e128b3d6b653ae2b0346bdfacd51c0e
http://europepmc.org/articles/PMC7925194
http://europepmc.org/articles/PMC7925194
Autor:
Nam Hyuck Cho, Yuji Jeong, Jae-Ouk Kim, Jung-ah Choi, Hyeja Lee, Semi Rho, Jae Myun Lee, Eunji Yang, Pil Gu Park, Dae Im Jung, Uni Park, Sang Hwan Seo, Young Shin Park, Junghyun Goo, Hyeyeong Sung, Manki Song
Publikováno v:
Virus Research
Highlights • Identification of neutralizing mAbs using MERS-CoV spike-pseudotyped virus. • Transmembrane domain-deleted spike subunit protein induced neutralizing antibodies. • Neutralizing antibodies could bind to RBD of MERS-CoV spike, but no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b62aa0db7071ae838dd0020a735015b
Autor:
In Su Cheon, Joo Young Kim, Youngjoo Choi, Byoung-Shik Shim, Jung-ah Choi, Dae-Im Jung, Jae-Ouk Kim, Thomas J. Braciale, Hyewon Youn, Man Ki Song, Jun Chang
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Frontiers in Immunology
Frontiers in Immunology
Respiratory syncytial virus (RSV) is the leading cause of serious respiratory tract disease but there is no licensed RSV vaccine. Immunopathological mechanisms have long been suspected as operating in the development of severe RSV disease and have ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74ae9ba69569334cc6de89942d0f655f
https://doi.org/10.3389/fimmu.2019.00567
https://doi.org/10.3389/fimmu.2019.00567
Autor:
Seo Ri Wui, Yeon Jeong Lee, Hien Thi Thu Do, Dae Im Jung, Ji In Ryu, Na Gyong Lee, Manki Song, Inmoo Rhee, Jin-Ah Park, Ara Ko, Jung-ah Choi, Soo Jeong Lim
Publikováno v:
Archives of pharmacal research. 41(2)
Adjuvants are essential vaccine components used to enhance, accelerate, and/or prolong adaptive immunity against specific vaccine antigens. In this study, we compared the adjuvanticity of two adjuvant formulations containing de-O-acylated lipooligosa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf1317de4488f976eead675f91c3a111
https://pubmed.ncbi.nlm.nih.gov/29147873
https://pubmed.ncbi.nlm.nih.gov/29147873
Autor:
Eugene Lee, Jae-Ouk Kim, Jung-ah Choi, Cecil Czerkinsky, Cheol-Heui Yun, Sung-Moo Park, Dae-Im Jung, Manki Song, Byoung-Shik Shim, Young Joo Choi, Eunji Yang, June Young Chun, In Su Cheon
Publikováno v:
Journal of Immunology Research
Journal of Immunology Research, Vol 2018 (2018)
Journal of Immunology Research, Vol 2018 (2018)
Potential use of cholera toxin (CT) as a mucosal vaccine adjuvant has been documented in a variety of animal models. However, native CT is highly toxic to be used as a mucosal adjuvant in humans. Here, we demonstrate a new approach to generate a muco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23b2c8889a452d617032bee276c097e0
https://pubmed.ncbi.nlm.nih.gov/29707588
https://pubmed.ncbi.nlm.nih.gov/29707588
Autor:
In-Young Yang, Sae-Hae Kim, Sun-Hee Jang, Ninh Uyen Truong, Thuc Van Pham, Ju Kim, Thang Thua Truong, Yong-Suk Jang, Kyung-Yeol Lee, Dae-Im Jung
Publikováno v:
International Immunology. 25:623-632
Oral mucosal vaccination is an alternative method to overcome the pitfalls of current injection-based vaccines, such as pain and high cost of vaccination. It is a feasible and economic vaccine application, especially in developing countries. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f4408259a92f940bba6e2b3b41b81bf
https://doi.org/10.1093/intimm/dxt029
https://doi.org/10.1093/intimm/dxt029